Amgen
(NASDAQ:AMGN)
243.87
0.47[0.19%]
At close: May 16
244.59
0.7200[0.30%]
After Hours: 5:55PM EDT
Day High/Low241.16 - 245.11
52 Week High/Low198.64 - 258.45
Open / Close241.24 / 243.87
Float / Outstanding533.6M / 534.2M
Vol / Avg.2.4M / 3.2M
Mkt Cap130.3B
P/E24.07
50d Avg. Price241.44
Div / Yield7.76/3.18%
Payout Ratio71.27
EPS2.69
Total Float533.6M

Amgen (NASDAQ:AMGN), Quotes and News Summary

Amgen (NASDAQ: AMGN)

Day High/Low241.16 - 245.11
52 Week High/Low198.64 - 258.45
Open / Close241.24 / 243.87
Float / Outstanding533.6M / 534.2M
Vol / Avg.2.4M / 3.2M
Mkt Cap130.3B
P/E24.07
50d Avg. Price241.44
Div / Yield7.76/3.18%
Payout Ratio71.27
EPS2.69
Total Float533.6M
Benzinga - Apr 28, 2022, 11:02AM
load more
Sector: Health Care.Industry: Biotechnology
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS4.1504.250 0.1000
REV6.110B6.238B128.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Amgen Questions & Answers

Q
How do I buy Amgen (AMGN) stock?
A

You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for Amgen (AMGN) stock?
A

The latest price target for Amgen (NASDAQ: AMGN) was reported by Mizuho on Tuesday, May 10, 2022. The analyst firm set a price target for 208.00 expecting AMGN to fall to within 12 months (a possible -14.71% downside). 26 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Amgen (AMGN)?
A

The stock price for Amgen (NASDAQ: AMGN) is $243.87 last updated May 16, 2022, 8:00 PM UTC.

Q
Does Amgen (AMGN) pay a dividend?
A

A quarterly cash dividend of $1.94 per share of Class A Common Stock. The quarterly cash dividend was payable on June 8, 2022 to stockholders of record on May 16, 2022.

Q
When is Amgen (NASDAQ:AMGN) reporting earnings?
A

Amgen’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is Amgen (AMGN) going to split?
A

There is no upcoming split for Amgen.

Q
What sector and industry does Amgen (AMGN) operate in?
A

Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.